LAC Med Berhad (KLSE:LACMED)

LAC Med Berhad Statistics

Total Valuation

LAC Med Berhad has a market cap or net worth of MYR 320.00 million. The enterprise value is 260.29 million.

Market Cap	320.00M
Enterprise Value	260.29M

Important Dates

The next estimated earnings date is Friday, June 5, 2026.

Earnings Date	Jun 5, 2026
Ex-Dividend Date	n/a

Share Statistics

LAC Med Berhad has 400.00 million shares outstanding. The number of shares has increased by 19,900.00% in one year.

Current Share Class	400.00M
Shares Outstanding	400.00M
Shares Change (YoY)	+19,900.00%
Shares Change (QoQ)	+39,600.60%
Owned by Insiders (%)	81.27%
Owned by Institutions (%)	0.02%
Float	74.91M

Valuation Ratios

The trailing PE ratio is 14.59.

PE Ratio	14.59
Forward PE	n/a
PS Ratio	1.59
PB Ratio	2.69
P/TBV Ratio	2.76
P/FCF Ratio	n/a
P/OCF Ratio	543.29
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.23, with an EV/FCF ratio of -30.10.

EV / Earnings	11.86
EV / Sales	1.29
EV / EBITDA	8.23
EV / EBIT	8.57
EV / FCF	-30.10

Financial Position

The company has a current ratio of 1.91, with a Debt / Equity ratio of 0.23.

Current Ratio	1.91
Quick Ratio	1.67
Debt / Equity	0.23
Debt / EBITDA	0.87
Debt / FCF	-3.17
Interest Coverage	41.92

Financial Efficiency

Return on equity (ROE) is 26.24% and return on invested capital (ROIC) is 43.84%.

Return on Equity (ROE)	26.24%
Return on Assets (ROA)	10.43%
Return on Invested Capital (ROIC)	43.84%
Return on Capital Employed (ROCE)	25.32%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	1.83M
Profits Per Employee	199,436
Employee Count	110
Asset Turnover	1.11
Inventory Turnover	5.89

Taxes

In the past 12 months, LAC Med Berhad has paid 8.99 million in taxes.

Income Tax	8.99M
Effective Tax Rate	29.12%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	1.03
200-Day Moving Average	n/a
Relative Strength Index (RSI)	30.40
Average Volume (20 Days)	1,386,780

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LAC Med Berhad had revenue of MYR 201.63 million and earned 21.94 million in profits. Earnings per share was 0.05.

Revenue	201.63M
Gross Profit	58.48M
Operating Income	30.39M
Pretax Income	30.86M
Net Income	21.94M
EBITDA	31.53M
EBIT	30.39M
Earnings Per Share (EPS)	0.05

Balance Sheet

The company has 87.22 million in cash and 27.45 million in debt, with a net cash position of 59.77 million or 0.15 per share.

Cash & Cash Equivalents	87.22M
Total Debt	27.45M
Net Cash	59.77M
Net Cash Per Share	0.15
Equity (Book Value)	118.86M
Book Value Per Share	0.30
Working Capital	105.30M

Cash Flow

In the last 12 months, operating cash flow was 589,000 and capital expenditures -9.24 million, giving a free cash flow of -8.65 million.

Operating Cash Flow	589,000
Capital Expenditures	-9.24M
Free Cash Flow	-8.65M
FCF Per Share	-0.02

Margins

Gross margin is 29.00%, with operating and profit margins of 15.07% and 10.88%.

Gross Margin	29.00%
Operating Margin	15.07%
Pretax Margin	15.31%
Profit Margin	10.88%
EBITDA Margin	15.64%
EBIT Margin	15.07%
FCF Margin	n/a

Dividends & Yields

LAC Med Berhad does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	22.79%
Buyback Yield	-19,900.00%
Shareholder Yield	-19,900.00%
Earnings Yield	6.86%
FCF Yield	-2.70%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LAC Med Berhad has an Altman Z-Score of 4 and a Piotroski F-Score of 6.

Altman Z-Score	4
Piotroski F-Score	6